NASDAQ:EYPT

Analysts Viewpoint

EyePoint Pharmaceuticals Inc (EYPT) rating initates by RBC Capital Mkts

Jaxson Clark

In a filing, EyePoint Pharmaceuticals Inc revealed its Chief Medical Officer Ribeiro Ramiro unloaded Company’s shares for reported $31602.0 on ...

Insiders Updates

EyePoint Pharmaceuticals Inc (EYPT) may enjoy gains as insiders got busy in the recent days

Samantha Gray

EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May ...

Analysts Viewpoint

RBC Capital Mkts initates EyePoint Pharmaceuticals Inc (EYPT) rating to an Outperform

Samantha Gray

In a filing, EyePoint Pharmaceuticals Inc revealed its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May ...

News

EyePoint Pharmaceuticals Inc [EYPT] Investment Guide: What You Need to Know

Anna Perez

EyePoint Pharmaceuticals Inc’s recently made public that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.